IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 56 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $23,510 | +193.9% | 67,174 | +200.5% | 0.00% | – |
Q3 2022 | $8,000 | +33.3% | 22,356 | +70.2% | 0.00% | – |
Q2 2022 | $6,000 | +20.0% | 13,137 | +29.1% | 0.00% | – |
Q1 2022 | $5,000 | -44.4% | 10,172 | -39.5% | 0.00% | – |
Q4 2021 | $9,000 | +28.6% | 16,808 | +147.0% | 0.00% | – |
Q3 2021 | $7,000 | +250.0% | 6,805 | +390.3% | 0.00% | – |
Q2 2021 | $2,000 | -50.0% | 1,388 | -58.7% | 0.00% | – |
Q1 2021 | $4,000 | -81.8% | 3,364 | -43.5% | 0.00% | – |
Q4 2020 | $22,000 | +57.1% | 5,958 | -7.9% | 0.00% | – |
Q3 2020 | $14,000 | -6.7% | 6,471 | -24.1% | 0.00% | – |
Q2 2020 | $15,000 | +66.7% | 8,521 | +20.1% | 0.00% | – |
Q1 2020 | $9,000 | +12.5% | 7,097 | +55.2% | 0.00% | – |
Q4 2019 | $8,000 | -60.0% | 4,572 | -34.0% | 0.00% | – |
Q3 2019 | $20,000 | +5.3% | 6,930 | -3.3% | 0.00% | – |
Q2 2019 | $19,000 | +171.4% | 7,167 | +159.0% | 0.00% | – |
Q1 2019 | $7,000 | -83.3% | 2,767 | -81.7% | 0.00% | – |
Q4 2018 | $42,000 | -46.2% | 15,157 | +73.9% | 0.00% | – |
Q3 2018 | $78,000 | – | 8,714 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG Innovation Capital Partners III GP Ltd | 56,250 | $68,000 | 0.23% |
Virtu Financial LLC | 325,330 | $390,000 | 0.04% |
HOLLENCREST CAPITAL MANAGEMENT | 141,000 | $169,000 | 0.02% |
Clear Creek Financial Management, LLC | 49,696 | $60,000 | 0.01% |
Palo Alto Investors LP | 77,044 | $92,000 | 0.01% |
ACADIAN ASSET MANAGEMENT LLC | 738,620 | $886,000 | 0.00% |
MARSHALL WACE, LLP | 477,449 | $573,000 | 0.00% |
WADE G W & INC | 35,000 | $42,000 | 0.00% |
TWO SIGMA ADVISERS, LP | 599,471 | $719,000 | 0.00% |
BRYN MAWR TRUST Co | 33,892 | $41,000 | 0.00% |